-
1
-
-
0031464954
-
Suppression of long-term potentiation in hippocampal slices by copper
-
Doreulee N., Yanovsky Y., Haas H. L.: Suppression of long-term potentiation in hippocampal slices by copper. Hippocampus, 1997, 7, 666-669.
-
(1997)
Hippocampus
, vol.7
, pp. 666-669
-
-
Doreulee, N.1
Yanovsky, Y.2
Haas, H.L.3
-
2
-
-
0023232461
-
The dexamethasone suppression test: An overview of its current status in psychiatry
-
Glassman A. H. et al.: The dexamethasone suppression test: an overview of its current status in psychiatry. Amer. J. Psychiat., 1987, 144, 1253-1262.
-
(1987)
Amer. J. Psychiat.
, vol.144
, pp. 1253-1262
-
-
Glassman, A.H.1
-
4
-
-
0000551272
-
Is adaptation of NMDA receptors an obligatory step in antidepressant action?
-
New Pharmacological Strategies. Ed. Skolnick P., Humana Press, Totowa, New Jersey
-
Huang N.-Y., Layer R. T., Skolnick P.: Is adaptation of NMDA receptors an obligatory step in antidepressant action? In: Antidepressants. New Pharmacological Strategies. Ed. Skolnick P., Humana Press, Totowa, New Jersey, 1997, 125-143.
-
(1997)
Antidepressants
, pp. 125-143
-
-
Huang, N.-Y.1
Layer, R.T.2
Skolnick, P.3
-
5
-
-
0030880731
-
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness
-
Maes M., Vandoolaeghe E., Neels H., Demedts P., Wauters A., Meltzer H. Y., Altamura C., Desnyder R.: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol. Psychiat., 1997, 42, 349-358.
-
(1997)
Biol. Psychiat.
, vol.42
, pp. 349-358
-
-
Maes, M.1
Vandoolaeghe, E.2
Neels, H.3
Demedts, P.4
Wauters, A.5
Meltzer, H.Y.6
Altamura, C.7
Desnyder, R.8
-
6
-
-
0024745359
-
Trace element studies on Karachi population. Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders
-
Manser W. T., Altaf Khan M., Zaki Hasan K.: Trace element studies on Karachi population. Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders. J. Pakist. Med. Assoc., 1989, 39, 269-274.
-
(1989)
J. Pakist. Med. Assoc.
, vol.39
, pp. 269-274
-
-
Manser, W.T.1
Altaf Khan, M.2
Zaki Hasan, K.3
-
7
-
-
0027315752
-
Assessment of copper status: Effect of age and gender on reference ranges in healthy adults
-
Milne D. B., Johnson P. E.: Assessment of copper status: effect of age and gender on reference ranges in healthy adults. Clin. Chem., 1993, 39, 883-887.
-
(1993)
Clin. Chem.
, vol.39
, pp. 883-887
-
-
Milne, D.B.1
Johnson, P.E.2
-
8
-
-
0026234335
-
Levels of copper and zinc in depression
-
Narang R. L., Gupta K.. R., Narang A. P. S., Rajvir Singh: Levels of copper and zinc in depression. Indian J. Physiol. Pharmacol., 1991, 35, 272-274.
-
(1991)
Indian J. Physiol. Pharmacol.
, vol.35
, pp. 272-274
-
-
Narang, R.L.1
Gupta, K.R.2
Narang, A.P.S.3
Singh, R.4
-
9
-
-
0345148784
-
Serum trace elements in animal models and human depression. Part I
-
Nowak G., Ziȩba A., Dudek, D., Kroniak M., Szymaczek M., Schlegel-Zawadzka M.: Serum trace elements in animal models and human depression. Part I. Zinc. Hum. Psychopharmacol. Clin. Exp., 1999, 14, 83-86.
-
(1999)
Zinc. Hum. Psychopharmacol. Clin. Exp.
, vol.14
, pp. 83-86
-
-
Nowak, G.1
Ziȩba, A.2
Kroniak, M.3
Szymaczek, M.4
Schlegel-Zawadzka, M.5
-
10
-
-
0032524219
-
Antidepressant treatment influences group I of glutamate metobotropic receptors in slices from hippocampal CA1 region
-
Pilc A., Branski P., Pałucha A., Tokarski K., Bijak M.: Antidepressant treatment influences group I of glutamate metobotropic receptors in slices from hippocampal CA1 region. Eur. J. Pharmacol., 1998, 349, 83-87.
-
(1998)
Eur. J. Pharmacol.
, vol.349
, pp. 83-87
-
-
Pilc, A.1
Branski, P.2
Pałucha, A.3
Tokarski, K.4
Bijak, M.5
-
11
-
-
0008937216
-
Brain copper levels after anidepressant treatment
-
Eds. Collery Ph., Bratter P., Negretti de Brattner V., Khassanova L., Etienne J. C., John Libbey Eurotext, Paris
-
Schlegel-Zawadzka M., Krośniak M., Nowak G.: Brain copper levels after anidepressant treatment. In: Metal Ions in Biology and Medicine. Eds. Collery Ph., Bratter P., Negretti de Brattner V., Khassanova L., Etienne J. C., John Libbey Eurotext, Paris, 1998, vol. 5, 703-706.
-
(1998)
Metal Ions in Biology and Medicine
, vol.5
, pp. 703-706
-
-
Schlegel-Zawadzka, M.1
Krośniak, M.2
Nowak, G.3
-
12
-
-
0342358806
-
Alterations in serum and brain trace element levels after antidepressant treatment. Part II
-
in press
-
Schlegel-Zawadzka M., Nowak G.: Alterations in serum and brain trace element levels after antidepressant treatment. Part II. Copper. Biol. Tr. Elem. Res., 1999, in press.
-
(1999)
Copper. Biol. Tr. Elem. Res.
-
-
Schlegel-Zawadzka, M.1
Nowak, G.2
-
13
-
-
0344069726
-
Serum trace elements in animal model and human depression. Part II
-
Schlegel-Zawadzka M., Ziȩba A., Dudek D., Krośniak M., Szymaczek M., Nowak G.: Serum trace elements in animal model and human depression. Part II. Copper. Hum. Psychopharmacol. Clin. Exp., 1999, 14, 447-451.
-
(1999)
Copper. Hum. Psychopharmacol. Clin. Exp.
, vol.14
, pp. 447-451
-
-
Schlegel-Zawadzka, M.1
Ziȩba, A.2
Dudek, D.3
Krośniak, M.4
Szymaczek, M.5
Nowak, G.6
-
14
-
-
0031728254
-
Economic appraisal of antidepressant pharmacotherapy: Critical review of the literature and future directions
-
Sclar D. A., Skaer T. L., Robinson L. M., Stowers J. K.: Economic appraisal of antidepressant pharmacotherapy: critical review of the literature and future directions. Depress. Anxiety, 1998, 8, Suppl. 1, 121-127.
-
(1998)
Depress. Anxiety
, vol.8
, Issue.SUPPL. 1
, pp. 121-127
-
-
Sclar, D.A.1
Skaer, T.L.2
Robinson, L.M.3
Stowers, J.K.4
-
15
-
-
0030032399
-
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression
-
Skolnick P., Layer R. T., Popik P., Nowak G., Paul I. A., Trullas R.: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry, 1996, 29, 23-26.
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 23-26
-
-
Skolnick, P.1
Layer, R.T.2
Popik, P.3
Nowak, G.4
Paul, I.A.5
Trullas, R.6
|